Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesVVT Med Inc.

VVT Med Inc.

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
0.19 CAD 0.00(0%)
Last update at 2026-11-04T16:20:00Z
VOLUME
41000
Market Cap
15.37M

Momentum Score

…

VVT Med Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins. It offers V-BLOCK, a treatment kit for leg vein; VAR-01, a treatment kit for leg varicosities; VAR-02, a treatment kit for shallow varicosities; VAR-P " 06, a treatment kit for perforant veins failure; and Spider-01, a treatment kit for spider veins. The company was founded in 2004 and is based in Kfar Saba, Israel.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.15
Low
0.19
High
52 Week Price Range
0.15
Low
0.75
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public disclosures for VVT Med Inc. (VVTM.V) are limited and available corporate materials provide few verifiable details about its operations or product offerings. Because company information is sparse, major long-term growth drivers cannot be confirmed; investors may still find exposure to a small-cap healthcare issuer of interest but should review primary filings and management disclosures before drawing conclusions.

Material risks include limited transparency and disclosure, low trading liquidity and heightened volatility, and execution and governance risks typical of small, thinly followed issuers.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.19
Dividend Yield
-
Revenue TTM
0.11M
Revenue Per Share
0.02
Gross Profit TTM
0.06M
Debt / Equity
-
ROE
-
Net Debt
5.77M
ROCE
19.15%
Diluted EPS TTM
-0.06

Insight News

View All

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31
Type yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31
Income before tax -1.04M -2.20M -2.59M
Net income -1.04M -2.20M -2.59M
Selling general administrative 1.05M 1.31M 0.92M
Gross profit 0.37M 0.01M 0.01M
Reconciled depreciation 0.10M 0.09M 0.09M
Operating income -1.10M -1.75M -2.25M
Interest expense 0.40M 0.35M 0.22M
Tax provision 0.00M 0.00M 0.00M
Interest income 0.00M 0.00M 0.00M
Net interest income -0.41M -0.36M -0.23M
Total revenue 0.49M 0.04M 0.08M
Total operating expenses 1.59M 1.79M 2.33M
Cost of revenue 0.12M 0.04M 0.07M
Total other income expense net 0.47M -0.09M -0.11M
Net income from continuing ops -1.04M -2.20M -2.59M
Breakdown 2024-12-31 2023-12-31 2022-12-31
Type yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31
Total assets 0.98M 0.89M 0.89M
Total liab 7.37M 6.25M 4.42M
Total stockholder equity -6.38M -5.36M -3.54M
Other current liab 0.06M - -
Capital stock 0.02M 0.02M 0.02M
Retained earnings -20.66M -19.62M -17.43M
Cash 0.10M 0.07M 0.15M
Total current liabilities 6.71M 4.55M 3.65M
Net debt 5.77M 4.64M 2.75M
Short long term debt 5.50M 3.37M 2.49M
Total current assets 0.37M 0.34M 0.36M
Long term investments 0.04M 0.04M 0.04M
Short term investments 0.00M 0.01M -
Net receivables 0.03M 0.03M 0.04M
Long term debt 0.37M 1.34M 0.40M
Inventory 0.22M 0.20M 0.16M
Accounts payable 0.50M 0.58M 0.69M
Non current assets total 0.61M 0.55M 0.52M
Capital lease obligations 0.45M 0.38M 0.46M
Breakdown 2024-12-31 2023-12-31 2022-12-31
Type yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31
Net borrowings 0.96M 1.42M 1.91M
Total cash from financing activities 0.96M 1.28M 1.86M
Net income -1.04M -2.20M -2.59M
Change in cash 0.03M -0.08M -0.07M
Begin period cash flow 0.07M 0.15M 0.22M
End period cash flow 0.10M 0.07M 0.15M
Total cash from operating activities -0.91M -1.40M -1.93M
Depreciation 0.10M 0.09M 0.09M
Change to inventory -0.02M -0.04M -0.01M
Change to account receivables 0.01M 0.01M -0.01M
Capital expenditures 0.00M 0.00M 0.02M
Change in working capital -0.07M 0.02M 0.34M
Stock based compensation 0.00M 0.30M 0.00M
Other non cash items 0.14M 0.33M 0.23M
Free cash flow -0.91M -1.40M -1.95M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
VVTM
VVT Med Inc.		 -
-%		 0.19 - - 137.25 - 100.22
TLT
Theralase Technologies Inc.		 0.01
2.78%		 0.18 - - 90.07 82.51 90.31
CNVI
Conavi Medical Corp.		 -0.01
4.55%		 0.10 - - 66.65 - 95.30
PINK
Perimeter Medical Imaging AI Inc		 -
-%		 0.18 4.13 - 18.78 11.34 20.22
CHER
Cheelcare Inc.		 -
-%		 1.25 - - 20.92 106.42 21.26

Profile*

VVT Med Inc.

VVT Med Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins. It offers V-BLOCK, a treatment kit for leg vein; VAR-01, a treatment kit for leg varicosities; VAR-02, a treatment kit for shallow varicosities; VAR-P " 06, a treatment kit for perforant veins failure; and Spider-01, a treatment kit for spider veins. The company was founded in 2004 and is based in Kfar Saba, Israel.

Hasadna 6 st., Kfar Saba, Israel, 4442405

972 9 766 0480

https://www.vvtmed.com

Name Title Year Born
Mr. Erez Tetro CEO & Director NA
Mr. Dor Sneh CFO & Corporate Secretary NA
Mr. Gideon Vitkon Chief of Operations NA
Orly Efrati Vice President of Global Marketing NA
Ms. Orly Efraty Vice President of Global Marketing NA
Eyal Alon Vice President of Global Sales NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.50
+15.05%
DSV
CAD 11.02
+14.55%
USA
CAD 4.29
+13.19%
NUAG
CAD 7.70
+12.90%
GMIN
CAD 43.79
+12.86%
DRUG
CAD 26.11
-29.58%
HUT
CAD 68.98
-22.41%
UCU
CAD 2.09
-14.34%
VET
CAD 14.87
-14.29%
PHX
CAD 10.96
-13.56%

Equity Sectors*

  • Basic Materials

    +5.46%

  • Communication Services

    +3.38%

  • Consumer Cyclical

    +3.11%

  • Consumer Defensive

    +1.35%

  • Energy

    -4.79%

  • Financial Services

    +2.66%

  • Healthcare

    -0.72%

  • Industrials

    -0.11%

  • Real Estate

    +1.84%

  • Technology

    +1.05%

  • Utilities

    +0.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…